August 2015 | Contemporary Oncology®

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas

August 22, 2015

The characterization of molecular abnormalities implicated in the tumorigenesis of sarcomas is being increasingly applied to the classification, prognostication and, in particular situations, management of these diseases.

ASCO 2015: All About PD-1, But What's Next?

July 29, 2015

At the 2015 ASCO Annual Meeting, we witnessed an extraordinary explosion into the general oncology consciousness of the Programmed Death-1: Programmed Death Ligand-1 axis and drugs that target that interaction.